Skip to menu Skip to content Skip to footer

2019

Conference Publication

Correlation of Medicare Patient Volume and Online Ratings for Retinal Physicians

Miller, Christian X., Miller, Alexander G., Obri, Mark, Hornik, Joan H., Rowland, Douglas Y. and Miller, David G. (2019). Correlation of Medicare Patient Volume and Online Ratings for Retinal Physicians. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Vancouver Canada, Apr 28-May 02, 2019. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Correlation of Medicare Patient Volume and Online Ratings for Retinal Physicians

2019

Conference Publication

Surgical Outcomes and Patient Satisfaction in Vitrectomy for Vitreous Floaters

Pophal, Charles, Chandra, Rohit, Hornik, Joan H., Miller, David G., Singerman, Lawrence J., Zegarra, Hernando, Novak, Michael A., Pendergast, Scott D., Coney, Joseph M., Rao, Llewelyn J., Zakov, Z. Nicholas and Schartman, Jerome P. (2019). Surgical Outcomes and Patient Satisfaction in Vitrectomy for Vitreous Floaters. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Vancouver Canada, Apr 28-May 02, 2019. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Surgical Outcomes and Patient Satisfaction in Vitrectomy for Vitreous Floaters

2019

Conference Publication

Noncompliance in retinal clinical trials: an analysis of factors that predict loss to follow up in multiple prospective studies

Zhou, Brenda, Mitchell, Travis, Rusakevich, Alexander Michael, Brown, David M. and Wykoff, Charles Clifton (2019). Noncompliance in retinal clinical trials: an analysis of factors that predict loss to follow up in multiple prospective studies. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Vancouver Canada, Apr 28-May 02, 2019. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Noncompliance in retinal clinical trials: an analysis of factors that predict loss to follow up in multiple prospective studies

2019

Conference Publication

Efficacy of the 0.19 mg Fluocinolone Acetonide (FA<sub>c</sub>) Implant (ILUVIEN®) in a Multiphysician, Single-practice Setting - The Cleveland Experience

Daroszewski, Daniel C., Coney, Joseph M., Schartman, Jerome P., Miller, David G., Rao, Llewelyn J. and Zegarra, Hernando (2019). Efficacy of the 0.19 mg Fluocinolone Acetonide (FAc) Implant (ILUVIEN®) in a Multiphysician, Single-practice Setting - The Cleveland Experience. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Vancouver Canada, Apr 28-May 02, 2019. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Efficacy of the 0.19 mg Fluocinolone Acetonide (FA<sub>c</sub>) Implant (ILUVIEN®) in a Multiphysician, Single-practice Setting - The Cleveland Experience

2019

Conference Publication

Maternal and paternal effects on offspring internalising problems: findings from family data and extended GCTA analyses

Shahid, Eshim, Eilertsen, Espen, Hammerschlag, Anke, Sallis, Hannah, Qiao, Zhen, Evans, David, Ystrom, Eivind, Bartels, Meike and Middeldorp, Christel M. (2019). Maternal and paternal effects on offspring internalising problems: findings from family data and extended GCTA analyses. 27th World Congress of Psychiatric Genetics (WCPG), Los Angeles, CA, United States, 26-31 October, 2019. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/j.euroneuro.2019.07.034

Maternal and paternal effects on offspring internalising problems: findings from family data and extended GCTA analyses

2019

Conference Publication

Effects of assortative mating on estimates of SNP heritability

Keller, Matthew, de Candia, Teresa, Jones, Matt, Tahmasbi, Rasool, Evans, Luke, Evans, David, Eaves, Lindon, Yang, Jian, Visscher, Peter and Goddard, Mike (2019). Effects of assortative mating on estimates of SNP heritability. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, United States, 13-17 October 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.euroneuro.2017.08.016

Effects of assortative mating on estimates of SNP heritability

2019

Conference Publication

A large-scale deep-coverage whole genome sequencing to identify less common and rare variants associated with BMD and fractures: the NHLBI Trans-Omics for Precision Medicine (TOPMED) study

Hsu, Yi-Hsiang, Xu, Hanfei, Zhang, Xiaoyu, Liu, Ching-Ti, Montasser, May, Fu, Mao, O'Connell, Jeff, Perry, James, Salimi, Shabnam, Streeten, Elizabeth, Mitchell, Braxton D., Crandall, Carolyn, Delaney, Chris, Justice, Anne, Karasik, David, Wallace, Robert, Evans, David M., Tobias, Jonathan H., Richards, Brent, Blangero, John, Wiggins, Kerri, Jackson, Rebecca and Kiel, Douglas (2019). A large-scale deep-coverage whole genome sequencing to identify less common and rare variants associated with BMD and fractures: the NHLBI Trans-Omics for Precision Medicine (TOPMED) study. Annual Meeting of the American Society for Bone and Mineral Research, Orlando, FL, United States, 20-23 September 2019. Hoboken, NJ, United States: Wiley-Blackwell Publishing. doi: 10.1002/jbmr.3936

A large-scale deep-coverage whole genome sequencing to identify less common and rare variants associated with BMD and fractures: the NHLBI Trans-Omics for Precision Medicine (TOPMED) study

2019

Conference Publication

Using Mendelian randomization to estimate the causal effect of maternal (intrauterine) exposures on late onset offspring outcomes

Evans, David, Warrington, Nicole, Partida, Gabriel Cuellar and Hwang, Daniel (2019). Using Mendelian randomization to estimate the causal effect of maternal (intrauterine) exposures on late onset offspring outcomes. 49th Annual Meeting of the Behavior Genetics Association (BGA), Stockholm, Sweden, 26-29 June, 2019. New York, NY, United States: Springer New York LLC. doi: 10.1007/s10519-019-09973-8

Using Mendelian randomization to estimate the causal effect of maternal (intrauterine) exposures on late onset offspring outcomes

2019

Conference Publication

Identification and Validation of Targets for Osteoporosis: Evidence from Whole exome Sequencing in 42,263 individuals, CRISPR-Cas9 and murine models

Laurent, Laetitia, Zhou, Sirui, Forgetta, Vincenzo, Richards, J. Brent, Kemp, John P., Evans, David M., Pramatarova, Albena, Croucher, Peter I., Williams, Graham R., Bassett, J. H. Duncan and Goltzman, David (2019). Identification and Validation of Targets for Osteoporosis: Evidence from Whole exome Sequencing in 42,263 individuals, CRISPR-Cas9 and murine models. Annual Meeting of the American Society for Bone and Mineral Research, Orlando, FL, United States, 20-23 September, 2019. Hoboken, NJ United States: Wiley-Blackwell Publishing. doi: 10.1002/jbmr.3936

Identification and Validation of Targets for Osteoporosis: Evidence from Whole exome Sequencing in 42,263 individuals, CRISPR-Cas9 and murine models

2019

Conference Publication

Genes within the context of development: changes in genetic trait architectures during childhood and adolescence

St Pourcain, Beate, Eaves, Lindon, Verhoef, Ellen, Shapland, Chin Yang, Ring, Susan M., Fisher, Simon E., Medland, Sarah E., Evans, David and Smith, George Davey (2019). Genes within the context of development: changes in genetic trait architectures during childhood and adolescence. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, United States, 13-17 October 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.euroneuro.2017.06.071

Genes within the context of development: changes in genetic trait architectures during childhood and adolescence

2018

Conference Publication

Predictability of the 12-week dosing status at Week 48 for patients receiving brolucizumab in HAWK and HARRIER

Dugel, Pravin U., Lang, Gabriele Elisabeth, Razavi, Sam, Weichselberger, Andreas, Ogura, Yuichiro and Brown, David M. (2018). Predictability of the 12-week dosing status at Week 48 for patients receiving brolucizumab in HAWK and HARRIER. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Honolulu Hi, Apr 21-May 03, 2018. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Predictability of the 12-week dosing status at Week 48 for patients receiving brolucizumab in HAWK and HARRIER

2018

Conference Publication

Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)

Liu, John, Coney, Joseph, Schartman, Jerome, Miller, David G., Zegarra, Hernando and Rao, Llewelyn (2018). Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME). Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Honolulu Hi, Apr 21-May 03, 2018. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)

2018

Conference Publication

Intravitreal Aflibercept Injection (IAI) for Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

Brown, David M. (2018). Intravitreal Aflibercept Injection (IAI) for Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Honolulu Hi, Apr 21-May 03, 2018. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Intravitreal Aflibercept Injection (IAI) for Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

2018

Conference Publication

Suprachoroidal Space Alterations after Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients with Diabetic Macular Edema

Lampen, Shaun Ian Retief, Khurana, Rahul N., Brown, David M. and Wykoff, Charles Clifton (2018). Suprachoroidal Space Alterations after Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients with Diabetic Macular Edema. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Honolulu Hi, Apr 21-May 03, 2018. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Suprachoroidal Space Alterations after Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients with Diabetic Macular Edema

2018

Conference Publication

Dermatopathologic and Optical Coherence Tomography "Cracked Mud Sign" in Pseudoxanthoma Elasticum

Brown, Ashley E., Wykoff, Charles Clifton, Hsu, Sylvia and Brown, David M. (2018). Dermatopathologic and Optical Coherence Tomography "Cracked Mud Sign" in Pseudoxanthoma Elasticum. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Honolulu Hi, Apr 21-May 03, 2018. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Dermatopathologic and Optical Coherence Tomography "Cracked Mud Sign" in Pseudoxanthoma Elasticum

2018

Conference Publication

Clinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular DegenerationClinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular Degeneration

Elman, Michael J., Brown, David M., Kaiser, Peter K. and Slakter, Jason S. (2018). Clinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular DegenerationClinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular Degeneration. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Honolulu Hi, Apr 21-May 03, 2018. ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Clinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular DegenerationClinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular Degeneration

2018

Conference Publication

Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic disease

Beaumont, Robin N., Warrington, Nicole M., Horikoshi, Momoko, Day, Felix R., Ong, Ken K., McCarthy, Mark I., Perry, John R. B., Freathy, Rachel M. and Evans, David M. (2018). Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic disease. 27th Annual Meeting of the International-Genetic-Epidemiology-Society (IGES), San Diego, Ca, United States, 14-16 October 2018. Hoboken, NJ, United States: John Wiley & Sons.

Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic disease

2018

Conference Publication

The genetic architecture of hip statistical shape models suggests that endochondral bone formation makes an important contribution to hip shape

Baird, D., Evans, D. S., Gregory, J. S., Saunders, F. R., Giuraniuc, C. V., Barr, R. J., Aspden, R. M., Kamanu, F. K., Kiel, D. P., Orwoll, E. S., Cummings, S. R., Lane, N. E., Mullins, B. H., Williams, F. M., Richards, B., Wilson, S. G., Spector, T. D., Faber, B. G., Lawlor, D. A., Beck, T. J., Evans, D. M., Paternoster, L., Karasikl, D. and Tobias, J. H. (2018). The genetic architecture of hip statistical shape models suggests that endochondral bone formation makes an important contribution to hip shape. OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis, Liverpool, England, 26-29 April 2018. London, United Kingdom: Elsevier.

The genetic architecture of hip statistical shape models suggests that endochondral bone formation makes an important contribution to hip shape

2017

Conference Publication

Small cell lung carcinoma (SCLC) cell line screen of standard of care (etoposide/carboplatin) plus a third agent

Teicher, Beverly A., Selby, Michael, Silvers, Thomas, Laudeman, Julie, Reinhart, Russell, Delosh, Rene, Ogle, Chad, Parchment, Ralph, Krushkal, Julia, Sonkin, Dmitriy, Morris, Joel, Kunkel, Mark and Evans, David (2017). Small cell lung carcinoma (SCLC) cell line screen of standard of care (etoposide/carboplatin) plus a third agent. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington Dc, Apr 01-05, 2017. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2017-4831

Small cell lung carcinoma (SCLC) cell line screen of standard of care (etoposide/carboplatin) plus a third agent

2017

Conference Publication

A clinical pharmacodynamic biomarker assay that distinguishes potentially repairable, cytotoxic drug-induced DNA double strand breaks (DSBs) from DSBs associated with apoptotic cell death

Dull, Angie B., Wilsker, Deborah, Kinders, Robert J., Parchment, Ralph E., Evans, David, Teicher, Beverly A. and Doroshow, James H. (2017). A clinical pharmacodynamic biomarker assay that distinguishes potentially repairable, cytotoxic drug-induced DNA double strand breaks (DSBs) from DSBs associated with apoptotic cell death. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington Dc, Apr 01-05, 2017. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2017-3072

A clinical pharmacodynamic biomarker assay that distinguishes potentially repairable, cytotoxic drug-induced DNA double strand breaks (DSBs) from DSBs associated with apoptotic cell death